Researchers have developed a way to program immune cells to target glioblastoma and treat multiple sclerosis inflammation in mice. This technology will soon be tested in clinical trials for people with glioblastoma. Using a “molecular GPS” system, immune cells were guided into the brain to kill tumors without harming healthy tissue. The method was successful in mice and may be tested in clinical trials soon. The technology also showed promise in eliminating brain tumors and reducing inflammation in multiple sclerosis in mice. Researchers hope this approach will benefit patients with various brain-related diseases in the future.
Source link
New technology guides immune cells to fight brain cancer and multiple sclerosis
